Clinical trials targeting aging and age-related multimorbidity

Mark A. Espeland, Eileen M. Crimmins, Brandon R. Grossardt, Jill P. Crandall, Jonathan A L Gelfond, Tamara B. Harris, Stephen B. Kritchevsky, Joann E. Manson, Jennifer G. Robinson, Walter A Rocca, Marinella Temprosa, Fridtjof Thomas, Robert Wallace, Nir Barzilai

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Background: There is growing interest in identifying interventions that may increase health span by targeting biological processes underlying aging. The design of efficient and rigorous clinical trials to assess these interventions requires careful consideration of eligibility criteria, outcomes, sample size, and monitoring plans. Methods: Experienced geriatrics researchers and clinical trialists collaborated to provide advice on clinical trial design. Results: Outcomes based on the accumulation and incidence of age-related chronic diseases are attractive for clinical trials targeting aging. Accumulation and incidence rates of multimorbidity outcomes were developed by selecting at-risk subsets of individuals from three large cohort studies of older individuals. These provide representative benchmark data for decisions on eligibility, duration, and assessment protocols. Monitoring rules should be sensitive to targeting aging-related, rather than disease-specific, outcomes. Conclusions: Clinical trials targeting aging are feasible, but require careful design consideration and monitoring rules.

Original languageEnglish (US)
Pages (from-to)355-361
Number of pages7
JournalJournals of Gerontology - Series A Biological Sciences and Medical Sciences
Volume72
Issue number3
DOIs
StatePublished - 2016

Fingerprint

Comorbidity
Clinical Trials
Biological Phenomena
Benchmarking
Incidence
Geriatrics
Sample Size
Chronic Disease
Cohort Studies
Research Personnel
Health

Keywords

  • Chronic diseases
  • Clinical trial design
  • Geroscience

ASJC Scopus subject areas

  • Aging
  • Geriatrics and Gerontology

Cite this

Espeland, M. A., Crimmins, E. M., Grossardt, B. R., Crandall, J. P., Gelfond, J. A. L., Harris, T. B., ... Barzilai, N. (2016). Clinical trials targeting aging and age-related multimorbidity. Journals of Gerontology - Series A Biological Sciences and Medical Sciences, 72(3), 355-361. https://doi.org/10.1093/gerona/glw220

Clinical trials targeting aging and age-related multimorbidity. / Espeland, Mark A.; Crimmins, Eileen M.; Grossardt, Brandon R.; Crandall, Jill P.; Gelfond, Jonathan A L; Harris, Tamara B.; Kritchevsky, Stephen B.; Manson, Joann E.; Robinson, Jennifer G.; Rocca, Walter A; Temprosa, Marinella; Thomas, Fridtjof; Wallace, Robert; Barzilai, Nir.

In: Journals of Gerontology - Series A Biological Sciences and Medical Sciences, Vol. 72, No. 3, 2016, p. 355-361.

Research output: Contribution to journalArticle

Espeland, MA, Crimmins, EM, Grossardt, BR, Crandall, JP, Gelfond, JAL, Harris, TB, Kritchevsky, SB, Manson, JE, Robinson, JG, Rocca, WA, Temprosa, M, Thomas, F, Wallace, R & Barzilai, N 2016, 'Clinical trials targeting aging and age-related multimorbidity', Journals of Gerontology - Series A Biological Sciences and Medical Sciences, vol. 72, no. 3, pp. 355-361. https://doi.org/10.1093/gerona/glw220
Espeland, Mark A. ; Crimmins, Eileen M. ; Grossardt, Brandon R. ; Crandall, Jill P. ; Gelfond, Jonathan A L ; Harris, Tamara B. ; Kritchevsky, Stephen B. ; Manson, Joann E. ; Robinson, Jennifer G. ; Rocca, Walter A ; Temprosa, Marinella ; Thomas, Fridtjof ; Wallace, Robert ; Barzilai, Nir. / Clinical trials targeting aging and age-related multimorbidity. In: Journals of Gerontology - Series A Biological Sciences and Medical Sciences. 2016 ; Vol. 72, No. 3. pp. 355-361.
@article{12d3ba303d044912be3536ae27941be9,
title = "Clinical trials targeting aging and age-related multimorbidity",
abstract = "Background: There is growing interest in identifying interventions that may increase health span by targeting biological processes underlying aging. The design of efficient and rigorous clinical trials to assess these interventions requires careful consideration of eligibility criteria, outcomes, sample size, and monitoring plans. Methods: Experienced geriatrics researchers and clinical trialists collaborated to provide advice on clinical trial design. Results: Outcomes based on the accumulation and incidence of age-related chronic diseases are attractive for clinical trials targeting aging. Accumulation and incidence rates of multimorbidity outcomes were developed by selecting at-risk subsets of individuals from three large cohort studies of older individuals. These provide representative benchmark data for decisions on eligibility, duration, and assessment protocols. Monitoring rules should be sensitive to targeting aging-related, rather than disease-specific, outcomes. Conclusions: Clinical trials targeting aging are feasible, but require careful design consideration and monitoring rules.",
keywords = "Chronic diseases, Clinical trial design, Geroscience",
author = "Espeland, {Mark A.} and Crimmins, {Eileen M.} and Grossardt, {Brandon R.} and Crandall, {Jill P.} and Gelfond, {Jonathan A L} and Harris, {Tamara B.} and Kritchevsky, {Stephen B.} and Manson, {Joann E.} and Robinson, {Jennifer G.} and Rocca, {Walter A} and Marinella Temprosa and Fridtjof Thomas and Robert Wallace and Nir Barzilai",
year = "2016",
doi = "10.1093/gerona/glw220",
language = "English (US)",
volume = "72",
pages = "355--361",
journal = "Journals of Gerontology - Series A Biological Sciences and Medical Sciences",
issn = "1079-5006",
publisher = "Oxford University Press",
number = "3",

}

TY - JOUR

T1 - Clinical trials targeting aging and age-related multimorbidity

AU - Espeland, Mark A.

AU - Crimmins, Eileen M.

AU - Grossardt, Brandon R.

AU - Crandall, Jill P.

AU - Gelfond, Jonathan A L

AU - Harris, Tamara B.

AU - Kritchevsky, Stephen B.

AU - Manson, Joann E.

AU - Robinson, Jennifer G.

AU - Rocca, Walter A

AU - Temprosa, Marinella

AU - Thomas, Fridtjof

AU - Wallace, Robert

AU - Barzilai, Nir

PY - 2016

Y1 - 2016

N2 - Background: There is growing interest in identifying interventions that may increase health span by targeting biological processes underlying aging. The design of efficient and rigorous clinical trials to assess these interventions requires careful consideration of eligibility criteria, outcomes, sample size, and monitoring plans. Methods: Experienced geriatrics researchers and clinical trialists collaborated to provide advice on clinical trial design. Results: Outcomes based on the accumulation and incidence of age-related chronic diseases are attractive for clinical trials targeting aging. Accumulation and incidence rates of multimorbidity outcomes were developed by selecting at-risk subsets of individuals from three large cohort studies of older individuals. These provide representative benchmark data for decisions on eligibility, duration, and assessment protocols. Monitoring rules should be sensitive to targeting aging-related, rather than disease-specific, outcomes. Conclusions: Clinical trials targeting aging are feasible, but require careful design consideration and monitoring rules.

AB - Background: There is growing interest in identifying interventions that may increase health span by targeting biological processes underlying aging. The design of efficient and rigorous clinical trials to assess these interventions requires careful consideration of eligibility criteria, outcomes, sample size, and monitoring plans. Methods: Experienced geriatrics researchers and clinical trialists collaborated to provide advice on clinical trial design. Results: Outcomes based on the accumulation and incidence of age-related chronic diseases are attractive for clinical trials targeting aging. Accumulation and incidence rates of multimorbidity outcomes were developed by selecting at-risk subsets of individuals from three large cohort studies of older individuals. These provide representative benchmark data for decisions on eligibility, duration, and assessment protocols. Monitoring rules should be sensitive to targeting aging-related, rather than disease-specific, outcomes. Conclusions: Clinical trials targeting aging are feasible, but require careful design consideration and monitoring rules.

KW - Chronic diseases

KW - Clinical trial design

KW - Geroscience

UR - http://www.scopus.com/inward/record.url?scp=85016185737&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85016185737&partnerID=8YFLogxK

U2 - 10.1093/gerona/glw220

DO - 10.1093/gerona/glw220

M3 - Article

C2 - 28364543

AN - SCOPUS:85016185737

VL - 72

SP - 355

EP - 361

JO - Journals of Gerontology - Series A Biological Sciences and Medical Sciences

JF - Journals of Gerontology - Series A Biological Sciences and Medical Sciences

SN - 1079-5006

IS - 3

ER -